高级检索
    徐崇锐, 尹凯. 从实验室到临床,HER2抗体药物偶联物的发展之路[J]. 循证医学, 2022, 22(4): 207-211. DOI: 10.12019/j.issn.1671-5144.2022.04.004
    引用本文: 徐崇锐, 尹凯. 从实验室到临床,HER2抗体药物偶联物的发展之路[J]. 循证医学, 2022, 22(4): 207-211. DOI: 10.12019/j.issn.1671-5144.2022.04.004
    shu
    XU Chong-rui, YIN Kai. From Bench to Bedside, the Development Path of HER2 Antibody-Drug Conjugate[J]. Journal of Evidence-Based Medicine, 2022, 22(4): 207-211. DOI: 10.12019/j.issn.1671-5144.2022.04.004
    Citation: XU Chong-rui, YIN Kai. From Bench to Bedside, the Development Path of HER2 Antibody-Drug Conjugate[J]. Journal of Evidence-Based Medicine, 2022, 22(4): 207-211. DOI: 10.12019/j.issn.1671-5144.2022.04.004
    shu

    从实验室到临床,HER2抗体药物偶联物的发展之路

    From Bench to Bedside, the Development Path of HER2 Antibody-Drug Conjugate

      摘要
      • HTML全文
      • 参考文献(17)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回